Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2015 07:30 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Discusses Mechanism of Action of Its HBV Antiviral Program at 2nd ANRS HBV Cure Workshop

NEW YORK and PARIS, May 19, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) today announced that Adam Zlotnick, PhD, Assembly's Chief Scientific Advisor and Chair of its HBV &...
March 19, 2015 08:37 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Pricing of $75 Million Public Offering of Its Common Stock

NEW YORK, March 19, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) ("Assembly") announced today the pricing of an underwritten public offering of $75 million, or 5,555,555 shares of...
March 18, 2015 16:01 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Proposed Public Offering of Common Stock

NEW YORK, March 18, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) ("Assembly") announced today that it is commencing an underwritten public offering of its common stock pursuant to...
February 20, 2015 07:30 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at 2015 RBC Capital Markets Healthcare Conference

NEW YORK, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) today announced that it is participating in the 2015 RBC Capital Markets Healthcare Conference at the New York...
February 17, 2015 07:30 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces Senior Management Changes

NEW YORK, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) today announced a number of senior management changes. Derek Small has been named Chief Executive Officer, in...
December 03, 2014 08:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at Investor Conferences

NEW YORK, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB) today announced that it is participating in two investor conferences this week. The company has been invited to join...
October 01, 2014 08:29 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Announces $15.75 Million Registered Direct Offering

NEW YORK, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Assembly) (Nasdaq:ASMB) announced today that on October 1, 2014, it entered into an agreement with institutional investors for...
July 25, 2014 08:30 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Provides Update on Status of VEN 307

NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq:ASMB), a biopharmaceutical company developing innovative treatments for hepatitis B virus (HBV) and C....
July 14, 2014 07:00 ET | Source: Assembly Biosciences, Inc.

Ventrus Biosciences Becomes Assembly Biosciences as Stockholders Approve Merger With Assembly Pharmaceuticals, Inc.

NEW YORK, July 14, 2014 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS) today announced that its stockholders have approved the issuance of common stock in connection with the merger...
June 09, 2014 16:00 ET | Source: Assembly Biosciences, Inc.

Ventrus Biosciences Files and Commences Mailing of Definitive Proxy Materials for July 10th Annual Meeting

NEW YORK, June 9, 2014 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS) ("Ventrus" or the "Company") today announced that it has filed definitive proxy materials with the Securities and...